The regulatory and signaling functions of zinc ions in human cellular physiology

Cellular and Molecular Biology of Metals

Volumn , Issue , 2010, Pages 181-212

  Haase, Hajo ^a   Maret, Wolfgang ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054637697     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420059984     Document Type: Chapter

References (284)

1. Andreini, C., et al. Counting the zinc-proteins encoded in the human genome, J. Proteome Res., 5, 196, 2006.
2. Vallee, B.L. and Auld, D.S. Zinc coordination, function, and structure of zinc enzymes and other proteins, Biochemistry, 29, 5647, 1990.
3. Maret, W. Zinc and sulfur: A critical biological partnership, Biochemistry, 43, 3301, 2004.
4. Vallee, B.L. and Wacker, W.E.C. The Proteins (2nd edition). Academic Press, New York, 1970.
5. Auld, D.S. Zinc coordination sphere in biochemical zinc sites, Biometals, 14, 271, 2001.
6. Williams, R.J.P. and da Silva, J.J.R.F. The distribution of elements in cells, Coord. Chem. Rev., 200, 247, 2000.
7. O’Halloran, T.V. and Culotta, V.C. Metallochaperones, an intracellular shuttle service for metal ions. J. Biol. Chem., 275, 25057, 2000.
8. Kury, S., et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica, Nat. Genet., 31, 239, 2002.
9. Wang, K., et al. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet., 71, 66, 2002.
10. Chowanadisai, W., Lonnerdal, B., and Kelleher, S.L. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency, J. Biol. Chem., 281, 39699, 2006.
11. Chimienti, F., Favier, A., and Seve, M. ZnT-8, a pancreatic beta-cell-specific zinc transporter. Biometals, 18, 313, 2005.
12. Saxena, R., et al. Genome wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science, 316, 1331, 2007.
13. Scott, L.J., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 316, 1341, 2007.
14. Sladek, R., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445, 881, 2007.
15. Zeggini, E., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes, Science, 316, 1336, 2007.
16. Giacconi, R., et al. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol. Genet. Metab., 94, 98, 2008.
17. Yang, L., et al. Polymorphisms in metallothionein-1 and 2 genes associated with the risk of type 2 diabetes mellitus and its complications, Am. J. Physiol. Endocrinol. Metab., 294, E987, 2008.
18. Maret, W., Larsen, K.S., and Vallee, B.L. Coordination dynamics of biological zinc “clusters” in metallothioneins and in the DNA-binding domain of the transcription factor Gal4, Proc. Natl. Acad. Sci. USA, 94, 2233, 1997.
19. Outten, C.E. and O’Halloran, T.V. Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis, Science, 292, 2488, 2001.
20. Adebodun, F. and Post, J.F. Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines, J. Cell. Physiol., 163, 80, 1995.
21. Benters, J., et al. Study of the interactions of cadmium and zinc ions with cellular calcium homoeostasis using 19F-NMR spectroscopy, Biochem. J., 322, 793, 1997.
22. Simons, T.J. Intracellular free zinc and zinc buffering in human red blood cells, J. Membr. Biol., 123, 63, 1991.
23. Peck, E.J., Jr. and Ray, W.J., Jr. Metal complexes of phosphoglucomutase in vivo. Alterations induced by insulin, J. Biol. Chem., 246, 1160, 1971.
24. 2+ homeostasis in neurons from experimental and modeling studies, Am. J. Physiol. Cell Physiol., 294, C726, 2008.
25. Bozym, R.A., et al. Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor, ACS Chem. Biol., 1, 103, 2006.
26. Haase, H., et al. Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells, Anal. Biochem., 352, 222, 2006.
27. Krezel, A. and Maret, W. Zinc buffering capacity of a eukaryotic cell at physiological pZn. J. Biol. Inorg. Chem., 11, 1049, 2006.
28. Krezel, A. and Maret, W. Thionein/metallothionein control Zn(II) availability and the activity of enzymes. J. Biol. Inorg. Chem., 13, 401, 2008.
29. Thomas, R.C., Coles, J.A., and Deitmer, J.W. Homeostatic muffling, Nature, 350, 564, 1991.
30. Aizenman, E., et al. Induction of neuronal apoptosis by thiol oxidation: Putative role of intracellular zinc release, J. Neurochem., 75, 1878, 2000.
31. Atar, D., et al. Excitation transcription coupling mediated by zinc influx through voltage-dependent calcium channels. J. Biol. Chem., 270, 2473, 1995.
32. Choi, D.W. and Koh, J.Y. Zinc and brain injury, Annu. Rev. Neurosci., 21, 347, 1998.
33. 2+ pools, Proc. Natl. Acad. Sci. USA, 100, 6157, 2003.
34. Smith, P.J., et al. DNA damage-induced [Zn(2+)](i) transients: Correlation with cell cycle arrest and apoptosis in lymphoma cells. Am. J. Physiol. Cell Physiol., 283, C609, 2002.
35. 2+ release, Proc. Natl. Acad. Sci. USA, 100, 13952, 2003.
36. St Croix, C.M., et al. Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein, Am. J. Physiol. Lung Cell Mol. Physiol., 282, L185, 2002.
37. 2+ concentration in rabbit ventricular myocytes, Am. J. Physiol., 272, H2095, 1997.
38. Giedroc, D.P., Chen, X., and Apuy, J.L. Metal response element (MRE)-binding transcription factor-1 (MTF-1): Structure, function, and regulation, Antioxid. Redox Signal., 3, 577, 2001.
39. Heuchel, R., et al. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression, EMBO J., 13, 2870, 1994.
40. Laity, J.H. and Andrews, G.K. Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1), Arch. Biochem. Biophys., 463, 201, 2007.
41. Palmiter, R.D., et al. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc. Natl. Acad. Sci. USA, 93, 14934, 1996.
42. Palmiter, R.D., Cole, T.B., and Findley, S.D. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J., 15, 1784, 1996.
43. Gaither, L.A. and Eide, D.J. The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells, J. Biol. Chem., 276, 22258, 2001.
44. Banci, L., et al. A new zinc-protein coordination site in intracellular metal trafficking: Solution structure of the Apo and Zn(II) forms of ZntA(46-118). J. Mol. Biol., 323, 883, 2002.
45. 2+ homeostasis. Plant Physiol., 136, 3712, 2004.
46. Hussain, D., et al. P-type ATPase heavy metal transporters with roles in essential zinc homeostasis in Arabidopsis. Plant Cell, 16, 1327, 2004.
47. Chao, Y. and Fu, D. Kinetic study of the antiport mechanism of an Escherichia coli zinc transporter, ZitB, J. Biol. Chem., 279, 12043, 2004.
48. Grass, G., et al. FieF (YiiP) from Escherichia coli mediates decreased cellular accumulation of iron and relieves iron stress. Arch. Microbiol., 183, 9, 2005.
49. Guffanti, A.A., et al. An antiport mechanism for a member of the cation diffusion facilitator family: Divalent cations efflux in exchange for K+ and H +, Mol. Microbiol., 45, 145, 2002.
50. MacDiarmid, C.W., Milanick, M.A., and Eide, D.J. B iochemical properties of vacuolar zinc transport systems of Saccharomyces cerevisiae. J. Biol. Chem., 277, 39187, 2002.
51. Gaither, L.A. and Eide, D.J. Functional expression of the human hZIP2 zinc transporter, J. Biol. Chem., 275, 5560, 2000.
52. Girijashanker, K., et al. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: Similarities to the ZIP8 transporter. Mol. Pharmacol., 73, 1413, 2008.
53. Ohana, E., et al. A sodium zinc exchange mechanism is mediating extrusion of zinc in mammalian cells. J. Biol. Chem., 279, 4278, 2004.
54. Lu, M. and Fu, D. Structure of the zinc transporter YiiP, Science, 317, 1746, 2007.
55. Jackson, K.A., et al. Splice variants of the human zinc transporter ZnT5 (SLC30A5) are differentially localized and regulated by zinc through transcription and mRNA stability, J. Biol. Chem., 282, 10423, 2007.
56. Ishihara, K., et al. Zinc transport complexes contribute to the homeostatic maintenance of secretory pathway function in vertebrate cells, J. Biol. Chem., 281, 17743, 2006.
57. Potter, B.M., et al. The six zinc fingers of metal-responsive element binding transcription factor-1 form stable and quasi-ordered structures with relatively small differences in zinc affinities, J. Biol. Chem., 280, 28529, 2005.
58. Cousins, R.J., et al. A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc. Natl. Acad. Sci. USA, 100, 6952, 2003.
59. Daniel, H. and tom Dieck, H. Nutrient gene interactions: A single nutrient and hundreds of target genes. Biol. Chem., 385, 571, 2004.
60. Haase, H., et al. Differential gene expression after zinc supplementation and deprivation in human leukocyte subsets, Mol. Med., 13, 362, 2007.
61. Li, Y. and Maret, W. Human metallothionein metallomics, J. Anal. Atom. Spectrom., 23, 1055, 2008.
62. Arseniev, A., et al. Three dimensional structure of rabbit liver [Cd7]metallothionein-2a in aqueous solution determined by nuclear magnetic resonance. J. Mol. Biol., 201, 637, 1988.
63. Robbins, A.H., et al. Refined crystal structure of Cd, Zn metallothionein at 2.0 A resolution. J. Mol. Biol., 221, 1269, 1991.
64. Krezel, A. and Maret, W. Different redox states of metallothionein/thionein in biological tissue, Biochem. J., 402, 551, 2007.
65. Yang, Y., Maret, W., and Vallee, B.L. Differential fluorescence labeling of cysteinyl clusters uncovers high tissue levels of thionein, Proc. Natl. Acad. Sci. USA, 98, 5556, 2001.
66. Krezel, A. and Maret, W. Dual nanomolar and picomolar Zn(II) binding properties of metallothionein, J. Am. Chem. Soc., 129, 10911, 2007.
67. Maret, W. and Vallee, B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters, Proc. Natl. Acad. Sci. USA, 95, 3478, 1998.
68. Maret, W., The function of zinc metallothionein: Alink between cellular zinc and redox state. J. Nutr., 130, 1455S, 2000.
69. Chen, Y. and Maret, W. Catalytic selenols couple the redox cycles of metallothionein and glutathione, Eur. J. Biochem., 268, 3346, 2001.
70. Pearce, L.L., et al. Metallothionein, nitric oxide and zinc homeostasis in vascular endothelial cells. J. Nutr., 130, 1467S, 2000.
71. Kroncke, K.D., et al. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9, Biochem. Biophys. Res. Commun., 200, 1105, 1994.
72. Stitt, M.S., et al. Nitric oxide-induced nuclear translocation of the metal responsive transcription factor, MTF-1 is mediated by zinc release from metallothionein, Vascul. Pharmacol., 44, 149, 2006.
73. Bossy-Wetzel, E., et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels, Neuron, 41, 351, 2004.
74. St Croix, C.M., et al. Nitric oxide and zinc homeostasis in acute lung injury, Proc. Am. Thorac. Soc., 2, 236, 2005.
75. Hao, Q. and Maret, W. Aldehydes release zinc from proteins. A pathway from oxidative stress/lipid peroxidation to cellular functions of zinc, FEBS J., 273, 4300, 2006.
76. Barbato, J.C., et al. Targeting of metallothionein by L-homocysteine: A novel mechanism for disruption of zinc and redox homeostasis, Arterioscler. Thromb. Vasc. Biol., 27, 49, 2007.
77. Maret, W., Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proc. Natl. Acad. Sci. USA, 91, 237, 1994.
78. Kang, Y.J., The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med., 222, 263, 1999.
79. Sato, M. and Bremner, I. Oxygen free radicals and metallothionein, Free Radic. Biol. Med., 14, 325, 1993.
80. Sagher, D., et al. Thionein can serve as a reducing agent for the methionine sulfoxide reductases, Proc. Natl. Acad. Sci. USA, 103, 8656, 2006.
81. Bray, T.M. and Bettger, W.J. The physiological role of zinc as an antioxidant, Free Radic. Biol. Med., 8, 281, 1990.
82. Powell, S.R., The antioxidant properties of zinc. J. Nutr., 130, 1447S, 2000.
83. Hao, Q. and Maret, W. Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease, J. Alzheimers Dis., 8, 161, 2005.
84. Krezel, A., Hao, Q., and Maret, W. The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling, Arch. Biochem. Biophys., 463, 188, 2007.
85. Hennig, B., et al. Antioxidant like properties of zinc in activated endothelial cells. J. Am. Coll. Nutr., 18, 152, 1999.
86. Ho, E., Courtemanche, C., and Ames, B.N. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts, J. Nutr., 133, 2543, 2003.
87. Oteiza, P.I., et al. Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells, Free Radic. Biol. Med., 28, 1091, 2000.
88. Dineley, K.E., Votyakova, T.V., and Reynolds, I.J. Zinc inhibition of cellular energy production: Implications for mitochondria and neurodegeneration, J. Neurochem., 85, 563, 2003.
89. Maret, W. and Krezel, A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease, Mol. Med., 13, 371, 2007.
90. Maret, W., Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp. Gerontol., 43, 363, 2008.
91. Cousins, R.J., Liuzzi, J.P., and Lichten, L.A. Mammalian zinc transport, trafficking, and signals, J. Biol. Chem., 281, 24085, 2006.
92. Haq, F., Mahoney, M., and Koropatnick, J. Signaling events for metallothionein induction, Mutat. Res., 533, 211, 2003.
93. Woo, E.S., et al. Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel, Cancer Chemother. Pharmacol., 41, 61, 1997.
94. Kägi, J.H.R., Evolution, structure and chemical activity of class I metallothioneins: An overview. In: Metallothionein III, K.T. Suzuki, N. Imura, and M. Kimura (eds), pp. 29-55. Birkhäuser, Basel, 1993.
95. Andrews, G.K., Regulation of metallothionein gene expression. Prog. Food Nutr. Sci., 14, 193, 1990.
96. Ghoshal, K. and Jacob, S.T. Regulation of metallothionein gene expression, Prog. Nucleic Acid Res. Mol. Biol., 66, 357, 2001.
97. Butler, J.S. and Loh, S.N. Zn(2+)-dependent misfolding of the p53 DNA binding domain. Biochemistry, 46, 2630, 2007.
98. Ye, B., Maret, W., and Vallee, B.L. Zinc metallothionein imported into liver mitochondria modulates respiration, Proc. Natl. Acad. Sci. USA, 98, 2317, 2001.
99. Apostolova, M.D., Ivanova, I.A., and Cherian, M.G. Signal transduction pathways, and nuclear translocation of zinc and metallothionein during differentiation of myoblasts, Biochem. Cell Biol., 78, 27, 2000.
100. Schmidt, C. and Beyersmann, D. Transient peaks in zinc and metallothionein levels during differentiation of 3T3L1 cells, Arch. Biochem. Biophys., 364, 91, 1999.
101. Takahashi, Y., Ogra, Y., and Suzuki, K.T. Nuclear trafficking of metallothionein requires oxidation of a cytosolic partner, J. Cell. Physiol., 202, 563, 2005.
102. Tsujikawa, K., et al. Localization of metallothionein in nuclei of growing primary cultured adult rat hepatocytes, FEBS Lett., 283, 239, 1991.
103. Woo, E.S., et al. Energy dependent nuclear binding dictates metallothionein localization. J. Cell. Physiol., 182, 69, 2000.
104. Moltedo, O., et al. Zinc transport and metallothionein secretion in the intestinal human cell line Caco-2, J. Biol. Chem., 275, 31819, 2000.
105. Trayhurn, P., et al. Regulation of metallothionein gene expression and secretion in rat adipocytes differentiated from preadipocytes in primary culture, Horm. Metab. Res., 32, 542, 2000.
106. De Lisle, R.C., et al. Metallothionein is a component of exocrine pancreas secretion: Implications for zinc homeostasis, Am. J. Physiol., 271, C1103, 1996.
107. 2+ or CdMT in proximal tubule cells: Different uptake routes and permissive role of endo/lysosomal CdMT uptake, Am. J. Physiol. Cell Physiol., 285, C1367, 2003.
108. Klassen, R.B., et al. Megalin mediates renal uptake of heavy metal metallothionein complexes, Am. J. Physiol. Renal Physiol., 287, F393, 2004.
109. Wolff, N.A., et al. Megalin dependent internalization of cadmium-metallothionein and cytotoxicity in cultured renal proximal tubule cells. J. Pharmacol. Exp. Ther., 318, 782, 2006.
110. Hao, Q., Hong, S.H., and Maret, W. Lipid raft-dependent endocytosis of metallothionein in HepG2 cells, J. Cell. Physiol., 210, 428, 2007.
111. Ambjorn, M., et al. Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family, J. Neurochem., 104, 21, 2008.
112. Fitzgerald, M., et al. Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp. Brain Res., 183, 171, 2007.
113. Chung, R.S., et al. Redefining the role of metallothionein within the injured brain: Extracellular metallothioneins play an important role in the astrocyte-neuron response to injury, J. Biol. Chem., 283, 15349, 2008.
114. Uchida, Y., et al. Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging, J. Biol. Chem., 277, 32353, 2002.
115. Uchida, Y., et al. The growth inhibitory factor that is deficient in the Alzheimer’s disease brain is a 68 amino acid metallothionein-like protein, Neuron, 7, 337, 1991.
116. Sewell, A.K., et al. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties, Biochemistry, 34, 4740, 1995.
117. Cole, T.B., et al. Seizures and neuronal damage in mice lacking vesicular zinc, Epilepsy Res., 39, 153, 2000.
118. Knipp, M., et al. Zn7metallothionein-3 and the synaptic vesicle cycle: Interaction of metallothionein-3 with the small GTPase Rab3A. Biochemistry, 44, 3159, 2005.
119. Thiers, R.E. and Vallee, B.L. Distribution of metals in subcellular fractions of rat liver, J. Biol. Chem., 226, 911, 1957.
120. Bartholomew, M.E., Tupper, R., and Wormall, A. Incorporation of Zn-65 in the sub-cellular fractions of the liver and spontaneously occurring mammary tumours of mice after the injection of zinc-glycine containing Zn-65, Biochem. J., 73, 256, 1959.
121. Weser, U. and Bischoff, E. Incorporation of 65Zn in rat liver nuclei, Eur. J. Biochem., 12, 571, 1970.
122. Haase, H. and Beyersmann, D. Intracellular zinc distribution and transport in C6 rat glioma cells, Biochem. Biophys. Res. Commun., 296, 923, 2002.
123. Zalewski, P.D., Forbes, I.J., and Betts, W.H. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II), Biochem. J., 296, 403, 1993.
124. Gazaryan, I.G., et al. Zinc irreversibly damages major enzymes of energy production and antioxidant defense prior to mitochondrial permeability transition, J. Biol. Chem., 282, 24373, 2007.
125. Williams, R.J.P., Zinc: What is its role in biology? Endeavour, 8, 65, 1984.
126. Maret, W., Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Signal., 8, 1419, 2006.
127. Berendji, D., et al. Nitric oxide mediates intracytoplasmic and intranuclear zinc release, FEBS Lett., 405, 37, 1997.
128. Korichneva, I., et al. Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen, J. Biol. Chem., 277, 44327, 2002.
129. Csermely, P. and Somogyi, J. Zinc as a possible mediator of signal transduction in T lymphocytes, Acta Physiol. Hung., 74, 195, 1989.
130. Haase, H. and Maret, W. Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases, J. Trace Elem. Med. Biol., 19, 37, 2005.
131. Yamasaki, S., et al. Zinc is a novel intracellular second messenger, J. Cell Biol., 177, 637, 2007.
132. Beyersmann, D. and Haase, H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells, Biometals, 14, 331, 2001.
133. Grummt, F., et al. Zinc as a second messenger of mitogenic induction. Effects on diadenosine tetraphosphate (Ap4A) and DNA synthesis, Exp. Cell Res., 163, 191, 1986.
134. Petrie, L., Chesters, J.K., and Franklin, M. Inhibition of myoblast differentiation by lack of zinc, Biochem. J., 276, 109, 1991.
135. Cherian, M.G. and Apostolova, M.D. Nuclear localization of metallothionein during cell proliferation and differentiation, Cell. Mol. Biol. (Noisy-le-grand), 46, 347, 2000.
136. Quarterman, J., Mills, C.F., and Humphries, W.R. The reduced secretion of, and sensitivity to insulin in zinc-deficient rats, Biochem. Biophys. Res. Commun., 25, 354, 1966.
137. Scott, D.A. and Fisher, A.M. The insulin and the zinc content of normal and diabetic pancreas, J. Clin. Invest., 17, 725, 1938.
138. Coulston, L. and Dandona, P. Insulin like effect of zinc on adipocytes. Diabetes, 29, 665, 1980.
139. May, J.M. and Contoreggi, C.S. The mechanism of the insulin-like effects of ionic zinc, J. Biol. Chem., 257, 4362, 1982.
140. Wong, V.V., et al. Zinc as an insulin replacement in hybridoma cultures, Biotechnol. Bioeng., 93, 553, 2006.
141. Haase, H. and Maret, W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling, Exp. Cell Res., 291, 289, 2003.
142. Tang, X. and Shay, N.F. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes, J. Nutr., 131, 1414, 2001.
143. Samet, J.M., et al. Mechanisms of Zn(2+)-induced signal initiation through the epidermal growth factor receptor, Toxicol. Appl. Pharmacol., 191, 86, 2003.
144. Samet, J.M., et al. Activation of MAPKs in human bronchial epithelial cells exposed to metals, Am. J. Physiol., 275, L551, 1998.
145. Wu, W., et al. Zinc induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J. Biol. Chem., 278, 28258, 2003.
146. Wu, W., et al. Src dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation. J. Biol. Chem., 277, 24252, 2002.
147. Hansson, A., Extracellular zinc ions induces mitogen-activated protein kinase activity and protein tyrosine phosphorylation in bombesin-sensitive Swiss 3T3 fibroblasts. Arch. Biochem. Biophys., 328, 233, 1996.
148. An, W.L., et al. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells, J. Neurochem., 92, 1104, 2005.
149. Park, J.A. and Koh, J.Y. Induction of an immediate early gene egr-1 by zinc through extracellular signalregulated kinase activation in cortical culture: Its role in zinc-induced neuronal death, J. Neurochem., 73, 450, 1999.
150. Zhang, Y., et al. Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes, J. Biol. Chem., 281, 9460, 2006.
151. Bruinsma, J.J., et al. Zinc ions and cation diffusion facilitator proteins regulate Ras-mediated signaling, Dev. Cell., 2, 567, 2002.
152. Yoder, J.H., et al. Modulation of KSR activity in Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase, EMBO J., 23, 111, 2004.
153. 2+, Brain Res., 557, 103, 1991.
154. Csermely, P., et al. Zinc increases the affinity of phorbol ester receptor in T lymphocytes, Biochem. Biophys. Res. Commun., 154, 578, 1988.
155. Forbes, I.J., et al. Interaction between protein kinase C and regulatory ligand is enhanced by a chelatable pool of cellular zinc, Biochim. Biophys. Acta., 1053, 113, 1990.
156. Zalewski, P.D., et al. Synergy between zinc and phorbol ester in translocation of protein kinase C to cytoskeleton, FEBS Lett., 273, 131, 1990.
157. Forbes, I.J., et al. Zinc induces specific association of PKC with membrane cytoskeleton, Biochem. Int., 22, 741, 1990.
158. Zalewski, P.D., et al. Regulation of protein kinase C by Zn(2+)-dependent interaction with actin, Biochem. Int., 24, 1103, 1991.
159. Palmer, B.M., et al. Intracellular distributions of essential elements in cardiomyocytes, J. Struct. Biol., 155, 12, 2006.
160. Lichtlen, P. and Schaffner, W. The “metal transcription factor” MTF-1: Biological facts and medical implications. Swiss Med. Wkly., 131, 647, 2001.
161. Lichtlen, P., et al. Target gene search for the metal-responsive transcription factor MTF-1, Nucleic Acids Res., 29, 1514, 2001.
162. Langmade, S.J., et al. The transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene, J. Biol. Chem., 275, 34803, 2000.
163. Radtke, F., et al. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter, EMBO J., 12, 1355, 1993.
164. Chen, X., Chu, M., and Giedroc, D.P. MRE-Binding transcription factor-1: Weak zinc-binding finger domains 5 and 6 modulate the structure, affinity, and specificity of the metal-response element complex. Biochemistry, 38, 12915, 1999.
165. Jiang, H., Daniels, P.J., and Andrews, G.K. Putative zinc-sensing zinc fingers of metal-response elementbinding transcription factor-1 stabilize a metal-dependent chromatin complex on the endogenous metallothionein-I promoter, J. Biol. Chem., 278, 30394, 2003.
166. Koizumi, S., et al. Roles of zinc fingers and other regions of the transcription factor human MTF-1 in zinc-regulated DNA binding, J. Cell. Physiol., 185, 464, 2000.
167. LaRochelle, O., et al. Phosphorylation is involved in the activation of metal-regulatory transcription factor 1 in response to metal ions, J. Biol. Chem., 276, 41879, 2001.
168. Saydam, N., et al. Regulation of metallothionein transcription by the metal-responsive transcription factor MTF-1: Identification of signal transduction cascades that control metal-inducible transcription, J. Biol. Chem., 277, 20438, 2002.
169. Zhang, B., et al. Activity of metal-responsive transcription factor 1 by toxic heavy metals and H2O2 in vitro is modulated by metallothionein, Mol. Cell. Biol., 23, 8471, 2003.
170. Brautigan, D.L., Bornstein, P., and Gallis, B. Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn, J. Biol. Chem., 256, 6519, 1981.
171. Maret, W., et al. Inhibitory sites in enzymes: Zinc removal and reactivation by thionein, Proc. Natl. Acad. Sci. USA, 96, 1936, 1999.
172. Conti, M. and Beavo, J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: Essential components in cyclic nucleotide signaling, Annu. Rev. Biochem., 76, 481, 2007.
173. Percival, M.D., Yeh, B., and Falgueyret, J.P. Zinc dependent activation of cAMP-specific phosphodiesterase (PDE4A), Biochem. Biophys. Res. Commun., 241, 175, 1997.
174. Pillai, R., Staub, S.F., and Colicelli, J. Mutational mapping of kinetic and pharmacological properties of a human cardiac cAMP phosphodiesterase, J. Biol. Chem., 269, 30676, 1994.
175. von Bulow, V., Rink, L., and Haase, H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3′,5′-cyclic monophosphate. J. Immunol., 175, 4697, 2005.
176. von Bulow, V., et al. Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B. J. Immunol., 179, 4180, 2007.
177. 2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol., 290, L1028, 2006.
178. Kim, P.W., et al. A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8. Science, 301, 1725, 2003.
179. Romir, J., et al. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs, J. Mol. Biol., 365, 1417, 2007.
180. 2+, FEBS Lett., 281, 278, 1991.
181. Danscher, G. and Stoltenberg, M. Zinc specific autometallographic in vivo selenium methods: Tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells. J. Histochem. Cytochem., 53, 141, 2005.
182. Frederickson, C.J., Koh, J.Y., and Bush, A.I. The neurobiology of zinc in health and disease, Nat. Rev. Neurosci., 6, 449, 2005.
183. Petrat, F., et al. The chelatable iron pool in living cells: A methodically defined quantity, Biol. Chem., 383, 489, 2002.
184. Nitzan, Y.B., Sekler, I., and Silverman, W.F. Histochemical and histofluorescence tracing of chelatable zinc in the developing mouse, J. Histochem. Cytochem., 52, 529, 2004.
185. Schroeder, H.A., et al. Essential trace metals in man: Zinc. Relation to environmental cadmium, J. Chronic. Dis., 20, 179, 1967.
186. Costello, L.C., et al. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells, J. Biol. Chem., 272, 28875, 1997.
187. Franklin, R.B. and Costello, L.C. Zinc as an anti-tumor agent in prostate cancer and in other cancers, Arch. Biochem. Biophys., 463, 211, 2007.
188. Emami, N. and Diamandis, E.P. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin, J. Biol. Chem., 283, 3031, 2008.
189. 2+ and extracellular protease inhibitors, Eur. J. Biochem., 262, 781, 1999.
190. Malm, J., et al. Enzymatic action of prostate-specific antigen (PSA or hK3): Substrate specificity and regulation by Zn(2+), a tight-binding inhibitor, Prostate, 45, 132, 2000.
191. Debela, M., et al. Crystal structures of human tissue kallikrein 4: Activity modulation by a specific zinc binding site, J. Mol. Biol., 362, 1094, 2006.
192. Debela, M., et al. Structural basis of the zinc inhibition of human tissue kallikrein 5, J. Mol. Biol., 373, 1017, 2007.
193. Debela, M., et al. Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7, Proc. Natl. Acad. Sci. USA, 104, 16086, 2007.
194. Kristiansen, L.H., et al. Autometallography allows ultrastructural monitoring of zinc in the endocrine pancreas, Histochem. Cell Biol., 115, 125, 2001.
195. Matseshe, J.W., et al. Recovery of dietary iron and zinc from the proximal intestine of healthy man: Studies of different meals and supplements, Am. J. Clin. Nutr., 33, 1946, 1980.
196. Larsen, K.S. and Auld, D.S. Carboxypeptidase A: Mechanism of zinc inhibition. Biochemistry, 28, 9620, 1989.
197. Gomez-Ortiz, M., et al. Inhibition of carboxypeptidase A by excess zinc: Analysis of the structural determinants by X-ray crystallography, FEBS Lett., 400, 336, 1997.
198. Dunn, M.F. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer-a review. Biometals, 18, 295, 2005.
199. Foster, M.C., et al. Elemental composition of secretory granules in pancreatic islets of Langerhans, Biophys. J., 64, 525, 1993.
200. Liuzzi, J.P., et al. Responsive transporter genes within the murine intestinal-pancreatic axis form a basis of zinc homeostasis, Proc. Natl. Acad. Sci. USA, 101, 14355, 2004.
201. Chimienti, F., et al. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules, Diabetes, 53, 2330, 2004.
202. Chimienti, F., et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion, J. Cell Sci., 119, 4199, 2006.
203. Kambe, T., et al. Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells, J. Biol. Chem., 277, 19049, 2002.
204. 2+ release from pancreatic beta-cells at the level of single exocytotic events, Anal. Chem., 75, 3468, 2003.
205. Zalewski, P.D., et al. Video image analysis of labile zinc in viable pancreatic islet cells using a specific fluorescent probe for zinc, J. Histochem. Cytochem., 42, 877, 1994.
206. Porksen, N., et al. In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts, Am. J. Physiol., 273, E908, 1997.
207. Ishihara, H., et al. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells, Nat. Cell Biol., 5, 330, 2003.
208. Zhou, H., et al. Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes, 56, 1107, 2007.
209. Ravier, M.A. and Rutter, G.A. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells, Diabetes, 54, 1789, 2005.
210. MacDonald, P.E., et al. A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol., 5, e143, 2007.
211. Franklin, I., et al. Beta cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes, 54, 1808, 2005.
212. Maske, H., Über den topochemischen Nachweis von Zink in Ammonshorn verschiedener Säugetiere. Naturwissenschaften, 42, 424, 1955.
213. Haug, F.M., Electron microscopical localization of the zinc in hippocampal mossy fibre synapses by a modified sulfide silver procedure. Histochemie, 8, 355, 1967.
214. Dobrowolska, J., et al. Quantitative imaging of zinc, copper and lead in three distinct regions of the human brain by laser ablation inductively coupled plasma mass spectrometry, Talanta, 74, 717, 2008.
215. Frederickson, C.J. and Bush, A.I. Synaptically released zinc: Physiological functions and pathological effects, Biometals, 14, 353, 2001.
216. Paoletti, P., Ascher, P., and Neyton, J. High affinity zinc inhibition of NMDA NR1-NR2A receptors. J. Neurosci., 17, 5711, 1997.
217. Paoletti, P., et al. Zinc at glutamatergic synapses, Neuroscience, 158, 126, 2009.
218. Nagaya, N., et al. An intersubunit zinc binding site in rat P2X2 receptors, J. Biol. Chem., 280, 25982, 2005.
219. Hsiao, B., et al. Determinants of zinc potentiation on the alpha4 subunit of neuronal nicotinic receptors, Mol. Pharmacol., 69, 27, 2006.
220. Hirzel, K., et al. Hyperekplexia phenotype of glycine receptor alpha1 subunit mutant mice identifies Zn(2+) as an essential endogenous modulator of glycinergic neurotransmission, Neuron, 52, 679, 2006.
221. 2+, J. Neurosci., 21, 8015, 2001.
222. Huang, Y.Z., et al. Zinc mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron, 57, 546, 2008.
223. Sun, G. and Budde, R.J. Substitution studies of the second divalent metal cation requirement of protein tyrosine kinase CSK, Biochemistry, 38, 5659, 1999.
224. Gundelfinger, E.D., et al. A role for zinc in postsynaptic density assembly and plasticity? Trends Biochem. Sci., 31, 366, 2006.
225. Fernandez, J.R., Welsh, W.J., and Firestein, B.L. Structural characterization of the zinc binding domain in cytosolic PSD-95 interactor (cypin): Role of zinc binding in guanine deamination and dendrite branching, Proteins, 70, 873, 2008.
226. Kodirov, S.A., et al. Synaptically released zinc gates long-term potentiation in fear conditioning pathways, Proc. Natl. Acad. Sci. USA, 103, 15218, 2006.
227. Yamaguchi, M. and Fukagawa, M. Role of zinc in regulation of PTP activity in osteoblastic MC3T3-E1 cells: Zinc modulation of insulin-like growth factor-I’s effect, Calcif. Tissue Int., 76, 32, 2005.
228. Wuthier, R.E., Mechanism of Matrix Vesicle-Mediated Mineralization of Cartilage. Isi Atlas Sci. Biochem., 1, 231, 1988.
229. Sauer, G.R., et al. Intracellular zinc fluxes associated with apoptosis in growth plate chondrocytes, J. Cell. Biochem., 88, 954, 2003.
230. Giblin, L.J., et al. Zinc secreting Paneth cells studied by ZP fluorescence. J. Histochem. Cytochem., 54, 311, 2006.
231. Grahn, B.H., et al. Zinc and the eye, J. Am. Coll. Nutr., 20, 106, 2001.
232. Ugarte, M. and Osborne, N.N. Zinc in the retina, Prog. Neurobiol., 64, 219, 2001.
233. Stojanovic, A., Stitham, J., and Hwa, J. Critical role of transmembrane segment zinc binding in the structure and function of rhodopsin, J. Biol. Chem., 279, 35932, 2004.
234. Redenti, S., Ripps, H., and Chappell, R.L. Zinc release at the synaptic terminals of rod photoreceptors, Exp. Eye Res., 85, 580, 2007.
235. Underwood, E.J., Trace Elements in Human and Animal Nutrition, 4th ed. Academic Press, San Diego, 1977.
236. Kelleher, S.L. and Lonnerdal, B. Zip3 plays a major role in zinc uptake into mammary epithelial cells and is regulated by prolactin. Am. J. Physiol. Cell Physiol., 288, C1042, 2005.
237. Endre, L., Katona, Z., and Gyurkovits, K. Letter: Zinc deficiency and cellular immune deficiency in acrodermatitis enteropathica. Lancet, 1, 1196, 1975.
238. Dufner-Beattie, J., et al. The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc regulation of the zinc transporters ZIP4 and ZIP5, J. Biol. Chem., 279, 49082, 2004.
239. Wang, F., et al. The mammalian Zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells, J. Biol. Chem., 279, 51433, 2004.
240. Kambe, T., Weaver, B.P., and Andrews, G.K. The genetics of essential metal homeostasis during development, Genesis, 46, 214, 2008.
241. Glaser, R., et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection, Nat. Immunol., 6, 57, 2005.
242. 2+-free states, Biochemistry, 38, 1695, 1999.
243. Corbin, B.D., et al. Metal chelation and inhibition of bacterial growth in tissue abscesses, Science, 319, 962, 2008.
244. World Health Organization. The World Health Report, p. 83, 2002.
245. Fraker, P.J. and King, L.E. Reprogramming of the immune system during zinc deficiency, Annu. Rev. Nutr., 24, 277, 2004.
246. Shankar, A.H. and Prasad, A.S. Zinc and immune function: The biological basis of altered resistance to infection, Am. J. Clin. Nutr., 68, 447S, 1998.
247. Wellinghausen, N., Kirchner, H., and Rink, L. The immunobiology of zinc, Immunol. Today, 18, 519, 1997.
248. Fischer Walker, C. and Black, R.E. Zinc and the risk for infectious disease, Annu. Rev. Nutr., 24, 255, 2004.
249. Rink, L. and Haase, H. Zinc homeostasis and immunity, Trends Immunol., 28, 1, 2007.
250. Prasad, A.S., Zinc and immunity. Mol. Cell. Biochem., 188, 63, 1998.
251. Allen, J.I., et al. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency, J. Lab. Clin. Med., 102, 577, 1983.
252. Fraker, P.J. and King, L.E. A distinct role for apoptosis in the changes in lymphopoiesis and myelopoiesis created by deficiencies in zinc. FASEB J., 15, 2572, 2001.
253. King, L.E. and Fraker, P.J. Flow cytometric analysis of the phenotypic distribution of splenic lymphocytes in zinc-deficient adult mice, J. Nutr., 121, 1433, 1991.
254. Overbeck, S., Rink, L., and Haase, H. Modulating the immune response by oral zinc supplementation: A single approach for multiple diseases, Arch. Immunol. Ther. Exp. (Warsz.), 56, 15, 2008.
255. Gastinel, L.N., et al. Studies on the zinc binding site to the serum thymic factor, Biochim. Biophys. Acta, 797, 147, 1984.
256. Prasad, A.S., et al. Serum thymulin in human zinc deficiency, J. Clin. Invest., 82, 1202, 1988.
257. Beck, F.W., et al. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans, Am. J. Physiol., 272, E1002, 1997.
258. Cakman, I., et al. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly, Mech. Ageing Dev., 87, 197, 1996.
259. Duchateau, J., et al. Beneficial effects of oral zinc supplementation on the immune response of old people, Am. J. Med., 70, 1001, 1981.
260. Wellinghausen, N., Martin, M., and Rink, L. Zinc inhibits interleukin-1-dependent T cell stimulation, Eur. J. Immunol., 27, 2529, 1997.
261. Cook-Mills, J.M. and Fraker, P.J. Functional capacity of the residual lymphocytes from zinc-deficient adult mice, Br. J. Nutr., 69, 835, 1993.
262. Haase, H., Overbeck, S., and Rink, L. Zinc supplementation for the treatment or prevention of disease: Current status and future perspectives, Exp. Gerontol., 43, 394, 2008.
263. Fraker, P.J., et al. Regeneration of T-cell helper function in zinc-deficient adult mice, Proc. Natl. Acad. Sci. USA, 75, 5660, 1978.
264. Moulder, K. and Steward, M.W. Experimental zinc deficiency: Effects on cellular responses and the affinity of humoral antibody, Clin. Exp. Immunol., 77, 269, 1989.
265. Rajagopalan, S., et al. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J. Immunol., 155, 4143, 1995.
266. Rajagopalan, S. and Long, E.O. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells, J. Immunol., 161, 1299, 1998.
267. Vales-Gomez, M., et al. The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins, Proc. Natl. Acad. Sci. USA, 98, 1734, 2001.
268. Fernandes, G., et al. Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice, Proc. Natl. Acad. Sci. USA, 76, 457, 1979.
269. Gustafson, G.T., Heavy metals in rat mast cell granules. Lab. Invest., 17, 588, 1967.
270. Ho, L.H., et al. Labile zinc and zinc transporter ZnT4 in mast cell granules: Role in regulation of caspase activation and NF-kappaB translocation, J. Immunol., 172, 7750, 2004.
271. King, L.E. and Fraker, P.J. Zinc deficiency in mice alters myelopoiesis and hematopoiesis, J. Nutr., 132, 3301, 2002.
272. Hujanen, E.S., Seppa, S.T., and Virtanen, K. Polymorphonuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro, Biochim. Biophys. Acta., 1245, 145, 1995.
273. Haase, H., et al. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes, J. Immunol., 181, 6491, 2008.
274. Kabu, K., et al. Zinc is required for Fc epsilon RI-mediated mast cell activation, J. Immunol., 177, 1296, 2006.
275. Richter, M., et al. Zinc chelators inhibit eotaxin, RANTES, and MCP-1 production in stimulated human airway epithelium and fibroblasts, Am. J. Physiol. Lung Cell Mol. Physiol., 285, L719, 2003.
276. Beach, R.S., Gershwin, M.E., and Hurley, L.S. Gestational zinc deprivation in mice: Persistence of immunodeficiency for three generations, Science, 218, 469, 1982.
277. Widdowson, E.M., McCance, R.A., and Spray, C.M. The chemical composition of the human body, Clin. Sci., 10, 113, 1951.
278. Jackson, M.J., Physiology of zinc: General aspects. In: Zinc in Human Biology, C.F. Mills (ed.), pp. 1-14. Springer, London, 1989.
279. Vallee, B.L. and Gibson, J.G. The zinc content of normal human whole blood, plasma, leukocytes, and erythrocytes, J. Biol. Chem., 176, 445, 1948.
280. King, J.C. and Cousins, R.J. Zinc. In: Modern Nutrition in Health and Disease, M.E. Shils et al. (eds), pp. 271-285. Lippincott Williams & Wilkins, Philadelphia, 2006.
281. Windisch, W. Development of zinc deficiency in 65Zn labeled, fully grown rats as a model for adult individuals, J. Trace Elem. Med. Biol., 17, 91, 2003.
282. Falchuk, K.H. Effect of acute disease and ACTH on serum zinc proteins, N. Engl. J. Med., 296, 1129, 1977.
283. Liuzzi, J.P., et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc. Natl. Acad. Sci. USA, 102, 6843, 2005.
284. Chesters, J.K. Zinc. In: Handbook of Nutritionally Essential Mineral Elements, B. O’Dell and R. Sunde (eds), pp. 185-230. Marcel Dekker, New York, 1997.